1. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer
- Author
-
Nazife Cevik, Berkcan Dogan, Samet Topuz, Taylan Şenol, Fatma Betül Ertem, Tuba Gunel, Mohammad Kazem Hosseini, Ece Gumusoglu, and Kılıç Aydınlı
- Subjects
0301 basic medicine ,Oncology ,Adult ,medicine.medical_specialty ,endocrine system diseases ,Microarray ,medicine.medical_treatment ,Carcinoma, Ovarian Epithelial ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diagnosis ,microRNA ,Biomarkers, Tumor ,Medicine ,Humans ,Ovarian Neoplasms ,Chemotherapy ,business.industry ,Microarray analysis techniques ,Area under the curve ,Obstetrics and Gynecology ,MicroRNA ,Biomarker ,General Medicine ,medicine.disease ,female genital diseases and pregnancy complications ,Human genetics ,Ovarian Cancer ,MicroRNAs ,030104 developmental biology ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,Female ,Neoplasm Recurrence, Local ,Recurrent ,business ,Ovarian cancer - Abstract
Çevik, Nazife (Arel Author), PurposeOvarian cancer (OC) is first gynaecologic cancer that causes women death and epithelial ovarian cancer (EOC) is the most lethal ovarian cancer type. While treatment is commonly successful, some cases (10-20%) show resistance to chemotherapy which is followed by recurrence. MicroRNA (miRNA) based diagnosis methods are slightly important for recurrent ovarian cancer diagnosis. We aimed to detect novel circulating miRNAs to be used as an early diagnosis and prediction tools for recurrent EOC.MethodsIn this study, recurrent EOC serum samples and healthy control serum samples were compared for miRNA expression analysis by microarray. Microarray results were analyzed by bioinformatics tools and differentially expressed hsa-miR-1273g-3p was obtained. After microarray analysis, differentially expressed hsa-miR-1273g-3p was validated by Real-Time PCR (RT-qPCR). The relation between target genes of hsa-miR-1273g-3p and ovarian cancer were examined by Pathway Studio((R)) (v.11.4.0.8).ResultsThe expression of hsa-miR-1273g-3p was found to be significantly down-regulated by t test Bonferroni FWER corrected p2, in recurrence EOC compare with healthy controls groups. The RT-qPCR results confirmed that relative expressions of the serum hsa-miR-1273g-3p were significantly down-regulated in patients with recurrent EOC (p=0.0275). Serum hsa-miR-1273g-3p levels could discriminate patients with recurrent EOC from healthy controls, with a power area under the curve (AUC) of 0.7.ConclusionThis study suggested that hsa-miR-1273g-3p plays a significant role in regulation of related genes, which are TNF-alfa, COL1A1, MMP-2, MMP-9, with recurrent EOC outcome. hsa-miR-1273g-3p may be used as a prognostic marker for recurrent EOC after chemotherapy.
- Published
- 2018